Thursday - May 22, 2025
$1M awarded to research link between cardiovascular risk reduction, GLP-1 use
April 29, 2025
DALLAS, Texas, April 29 [Category: Health Care] -- The American Heart Association posted the following news release:

* * *

$1M awarded to research link between cardiovascular risk reduction, GLP-1 use

DALLAS, April 29, 2025 -- Glucagon-like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) agonists -- originally developed to treat people with diabetes and obesity -- are showing promise for improving cardiovascular outcomes, but their effects can vary acr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products